LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 199 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $26,254,607 | -24.0% | 438,161 | -8.6% | 2.24% | -10.5% |
Q2 2023 | $34,568,128 | -2.3% | 479,447 | -0.3% | 2.50% | -2.8% |
Q1 2023 | $35,368,162 | +109443.0% | 480,807 | -0.5% | 2.57% | +2.1% |
Q4 2022 | $32,287 | -99.9% | 483,347 | -1.6% | 2.52% | -25.1% |
Q3 2022 | $42,289,000 | -4.4% | 491,107 | -1.0% | 3.37% | +1.8% |
Q2 2022 | $44,255,000 | -23.0% | 496,028 | -2.9% | 3.31% | -3.2% |
Q1 2022 | $57,464,000 | -28.3% | 510,843 | -1.6% | 3.41% | -25.7% |
Q4 2021 | $80,162,000 | +2.0% | 518,988 | -8.0% | 4.60% | +0.4% |
Q3 2021 | $78,625,000 | +0.8% | 564,349 | -5.1% | 4.58% | +9.6% |
Q2 2021 | $77,976,000 | -4.8% | 594,380 | +10.7% | 4.18% | -6.8% |
Q1 2021 | $81,869,000 | +28.2% | 537,028 | -16.4% | 4.48% | +16.2% |
Q4 2020 | $63,854,000 | +1.0% | 642,073 | -3.2% | 3.85% | -9.4% |
Q3 2020 | $63,233,000 | -12.7% | 663,383 | +2.4% | 4.25% | -18.1% |
Q2 2020 | $72,441,000 | +56.7% | 647,668 | +1.9% | 5.19% | +31.7% |
Q1 2020 | $46,232,000 | – | 635,758 | – | 3.94% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |